Oragenicsの空売り状況は、投資家がOragenicsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Oragenics (AMEX:OGEN) 株価情報, 空売り情報

Oragenics

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Oragenics Inc

Wedbush analyst Yun Zhong assumes Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) with a Outperform rating and announces Price Target of $4.

News

Price Target

Initiation

Analyst Ratings

PASG

Wedbush Assumes Passage Bio at Outperform, Announces Price Target of $4

WIIM

BGM Group shares are trading higher after the company announced its acquisition of the intelligent platform of AIX Inc., valued at approximately 1 billion RMB ($140 million).

Developmental-stage biopharmaceutical company Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares are<a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener"> trading higher on Friday</a>.
The company has announced a collaboration with Kymanox to develop a specialized subcutaneous insertion device for SP-26, its ketamine-loaded implant aimed at treating <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42243217/silo-pharma-enters-joint-development-agreement-for-sp-26-ketamine-implant-device-targeting-pain-ma" rel="noreferrer noopener">fibromyalgia and chronic pain</a>.
The agreement includes a proof-of-concept design phase followed by prototype testing to determine the optimal tissue insertion depth.
Silo Pharma&#8217;s CEO, Eric Weisblum, highlighted that previous trials have confirmed the implant&#8217;s optimal formulation, and the focus now shifts to refining the insertion device for preclinical studies.
&#8220;Now we are advancing this program to develop a novel insertion device that is intended to be tested in continuing preclinical studies,&#8221; Weisblum added.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42244387/nvidia-lam-reasearch-applied-materials-stocks-gain-as-biden-government-eyes-softer-semiconductor-sanctions-against-china" rel="noreferrer noopener">Nvidia, Chip Stocks Gain On Reports Of Softer China Sanctions</a>
If clinically successful, SP-26 could qualify for the FDA&#8217;s streamlined 505(b)(2) regulatory pathway for drug approval, the company said.
SP-26 is designed with the goal of meeting FDA safety standards for at-home use. In addition to the SP-26 project, Kymanox also serves as Silo&#8217;s regulatory partner for SPC-15, a treatment for stress-related disorders like PTSD.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, SILO stock has lost over 39% in the past year.
Price Action: SILO shares are trading higher by 6.68% to $0.9601 at last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42198109/nvidia-blackwell-supplier-vishay-intertechnology-likey-to-see-upside-courtesy-of-ai-frenzy-analyst" target="_blank" rel="noreferrer noopener">Nvidia Blackwell Supplier Vishay Intertechnology Likely To See Upside Courtesy Of AI Frenzy: Analyst</a></li>
</ul>
Photo via Shutterstock.

Equities

Markets

Movers

General

SILO

Why Is Silo Pharma Stock Gaining Today?

RBC Capital analyst Paul Treiber maintains Descartes Systems Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) with a Outperform and raises the price target from $115 to $133.

DSGX

RBC Capital Maintains Outperform on Descartes Systems Gr, Raises Price Target to $133

Trading Ideas

AIEV

Thunder Power Holdings Shares Halted On Circuit Breaker To Upside

RBC Capital analyst Brian Abrahams downgrades Applied Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) from Outperform to Sector Perform and lowers the price target from $12 to $4.

Downgrades

APLT

RBC Capital Downgrades Applied Therapeutics to Sector Perform, Lowers Price Target to $4

Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares are trading slightly lower in the morning session on Friday.
The company is making significant strides in modernizing its supply chain with the official launch of its <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42237680/yum-china-officially-launches-digital-supplier-recruitment-platform-at-china-international-supply-" rel="noreferrer noopener">digital supplier recruitment platform</a>.
Unveiled at the 2nd China International Supply Chain Expo, the platform invites high-quality enterprises globally to join the company&#8217;s expansive supply chain network.
This platform marks a shift from traditional supplier selection to a data-driven and interactive process. By enabling potential suppliers to submit their credentials online, Yum China simplifies the engagement process, significantly reducing the time and manual effort required for supplier evaluation.
It also promotes transparency and fairness in selection, aligning with the company&#8217;s &#8220;Spend Better, Buy Better&#8221; initiative aimed at enhancing operational efficiency.
Since its pilot launch in April 2024, the platform has already attracted applications across more than 30 categories, covering over a third of the company&#8217;s total categories.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42241785/us-futures-signal-gains-on-the-truncated-trading-day-will-december-witness-a-santa-claus-rally-analysts-decode" rel="noreferrer noopener">US Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode</a>
At the launch ceremony, Yum China also signed agreements with both domestic and international companies, focusing on sourcing and product innovation to improve the culinary experience for its customers.
Yum China&#8217;s supply chain management system already includes over 800 core suppliers across diverse categories, such as food ingredients, beverages, and packaging materials. Leveraging this vast network, the company delivers safe and diverse menu options tailored to the tastes of Chinese consumers.
For FY24, Yum China plans to open 1,500 to 1,700 new stores, invest $700 million to $850 million in capital expenditures, and return $1.5 billion to shareholders <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41709548/yum-china-q3-earnings-surprise-kfc-pizza-hut-power-earnings-beat-reiterates-capex-plan-to-open-1-50" rel="noreferrer noopener">through dividends and share repurchases</a>.
Price Action: YUMC shares are trading lower by 0.73% to $46.44 at last check Friday.
Read Next:
<ul>
<li><a href="http://gop%20megadonor%20ken%20griffin%20slashes%20citadel's%20palantir%20stake%20by%2091%25,%20bets%20big%20on%20nvidia%20as%20jensen%20huang-led%20company%20rises%20over%20180%25%20in%202024/" target="_blank" rel="noreferrer noopener">GOP Megadonor Ken Griffin Slashes Citadel&#8217;s Palantir Stake By 91%, Bets Big On Nvidia As Jensen Huang-Led Company Rises Over 180% In 2024</a></li>
</ul>
Photo by aleks-dorohovich- for Unsplash.

YUMC

Yum China Unveils New Platform For Supplier Recruitment With Speed And Transparency

Whales with a lot of money to spend have taken a noticeably bullish stance on Bank of America.
Looking at options history for Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $351,268 and 2, calls, for a total amount of $128,420.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $32.0 to $60.0 for Bank of America over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Bank of America stands at 5699.0, with a total volume reaching 4,464.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Bank of America, situated within the strike price corridor from $32.0 to $60.0, throughout the last 30 days.
<h3>Bank of America Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732893380_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$0.62</td>
<td>$0.6</td>
<td>$0.6</td>
<td>$45.00</td>
<td>$90.0K</td>
<td>3.8K</td>
<td>1.5K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.0</td>
<td>$15.85</td>
<td>$16.0</td>
<td>$32.00</td>
<td>$80.0K</td>
<td>21.1K</td>
<td>50</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.21</td>
<td>$2.17</td>
<td>$2.2</td>
<td>$49.00</td>
<td>$50.6K</td>
<td>1.1K</td>
<td>679</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$2.6</td>
<td>$2.53</td>
<td>$2.6</td>
<td>$49.00</td>
<td>$50.1K</td>
<td>305</td>
<td>194</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.23</td>
<td>$2.18</td>
<td>$2.22</td>
<td>$49.00</td>
<td>$50.1K</td>
<td>1.1K</td>
<td>225</td>
</tr>
</tbody>
</table>

<h3>About Bank of America</h3>
Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
Having examined the options trading patterns of Bank of America, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Bank of America Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,021,732, the BAC's price is down by -0.01%, now at $47.77. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 48 days.</li>
</ul>
<h3>Professional Analyst Ratings for Bank of America</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $55.333333333333336.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a positive move, an analyst from Citigroup has upgraded their rating to Buy and adjusted the price target to $54. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Bank of America, which currently sits at a price target of $56. 
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Bank of America with a target price of $56. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bank of America with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Bank of America's Options Frenzy: What You Need to Know

Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) revealed 14 unusual trades.
Delving into the details, we found 35% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $210,005, and 9 were calls, valued at $379,290.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $111.0 for Novo Nordisk over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $105.0 to $111.0, over the past month.
<h3>Novo Nordisk 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732893375_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/13/24</td>
<td>$5.6</td>
<td>$5.05</td>
<td>$5.29</td>
<td>$105.00</td>
<td>$159.0K</td>
<td>171</td>
<td align="right">300</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$8.35</td>
<td>$8.0</td>
<td>$8.2</td>
<td>$110.00</td>
<td>$42.6K</td>
<td>7.0K</td>
<td align="right">273</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.1</td>
<td>$110.00</td>
<td>$42.1K</td>
<td>7.0K</td>
<td align="right">116</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.1</td>
<td>$110.00</td>
<td>$42.1K</td>
<td>7.0K</td>
<td align="right">64</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$7.7</td>
<td>$7.5</td>
<td>$7.5</td>
<td>$109.00</td>
<td>$42.0K</td>
<td>351</td>
<td align="right">56</td>
</tr>
</tbody>
</table>

<h3>About Novo Nordisk</h3>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
<h3>Where Is Novo Nordisk Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 358,592, with NVO's price down by -0.65%, positioned at $105.44.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 61 days.</li>
</ul>
<h3>Expert Opinions on Novo Nordisk</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $160.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

What the Options Market Tells Us About Novo Nordisk

Deep-pocketed investors have adopted a bullish approach towards Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DIS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Walt Disney. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 12% bearish. Among these notable options, 2 are puts, totaling $139,292, and 6 are calls, amounting to $336,113.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $120.0 for Walt Disney during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Walt Disney's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Walt Disney's whale trades within a strike price range from $75.0 to $120.0 in the last 30 days. 
<h3>Walt Disney Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732893369_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$46.0</td>
<td>$44.8</td>
<td>$46.0</td>
<td>$75.00</td>
<td>$115.0K</td>
<td>376</td>
<td align="right">25</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$2.3</td>
<td>$2.27</td>
<td>$2.27</td>
<td>$115.00</td>
<td>$112.5K</td>
<td>3.4K</td>
<td align="right">522</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$8.0</td>
<td>$7.85</td>
<td>$8.0</td>
<td>$115.00</td>
<td>$85.6K</td>
<td>3.6K</td>
<td align="right">8</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$4.6</td>
<td>$4.5</td>
<td>$4.55</td>
<td>$120.00</td>
<td>$51.8K</td>
<td>3.5K</td>
<td align="right">136</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.82</td>
<td>$1.77</td>
<td>$1.82</td>
<td>$116.00</td>
<td>$29.4K</td>
<td>1.7K</td>
<td align="right">207</td>
</tr>
</tbody>
</table>

<h3>About Walt Disney</h3>
Disney operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from the firm's ownership of iconic franchises and characters. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses ESPN and the ESPN+ streaming service. Experiences contains Disney's theme parks and vacation destinations, and also benefits from merchandise licensing.
In light of the recent options history for Walt Disney, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Walt Disney Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 909,998, the DIS's price is down by -0.55%, now at $116.95. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 68 days.</li>
</ul>
<h3>What Analysts Are Saying About Walt Disney</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $127.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Evercore ISI Group persists with their Outperform rating on Walt Disney, maintaining a target price of $128. 
&#x2A; An analyst from Bernstein has decided to maintain their Outperform rating on Walt Disney, which currently sits at a price target of $120. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Walt Disney with a target price of $125. 
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Buy rating on Walt Disney with a target price of $125. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Walt Disney, which currently sits at a price target of $138. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Walt Disney with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Decoding Walt Disney's Options Activity: What's the Big Picture?

DevvStream Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>) announced an agreement to <a target="_blank" href="https://www.newsfilecorp.com/release/231880" rel="noreferrer noopener">acquire </a>all renewable and carbon assets from the Medellin Solar Power Facility in the form of international renewable energy certificates (I-RECs).
The Medellin Solar Power Facility, with a 730 MWp capacity, is part of the &#8220;2030 Smart City&#8221; plan in Cebu, Philippines. Developed by Sogod Energy Inc., it will generate 1.2 million I-RECs annually from 1.219 million MWh of energy.
I-RECs certify 1 MWh of renewable energy generated and injected into the grid. Organizations buy them to meet renewable energy goals, support clean energy, and report sustainability while ensuring credibility through the globally recognized I-REC Standard.
The agreement grants DevvStream full ownership of renewable energy and carbon assets, marking its entry into global energy transition markets. This milestone also advances the &#8220;Project Development&#8221; tier of the Company&#8217;s corporate strategy, reinforcing its role in sustainability.
The development of the Medellin Solar Power facility will proceed in three phases. Phase 1 is expected to be completed within 6 months, and the first I-RECs are anticipated to be produced approximately one month after its completion.
&#8220;While our roots are in carbon, DevvStream maintains a diverse asset portfolio, representing a range of environmental and energy transition assets,&#8221; said Sunny Trinh, CEO of DevvStream.
&#8220;I-RECs present a new opportunity for diversification and growth, particularly in the Asian segment, which accounts for approximately 70% of the world&#8217;s total installed solar capacity. To penetrate this market, we are starting with ASEAN member states, where demand is strong and prices are correspondingly higher. The rise of the I-REC market in Asia overall has been significant in recent years, offering DevvStream a strong path toward revenue while broadening the Company&#8217;s environmental impact and global reach.&#8221;
Price Action: DEVS shares are trading higher by 30.6% at $1.00 last check Friday.
Image via Shutterstock

DEVS

DevvStream Taps Asia's Soaring I-REC Market with Medellin Solar Deal; Stock Jumps

Bolt Projects Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) shares are moving higher on Friday. The company announced a private placement of 1.06 million shares at 34 cents per share. Here&#8217;s what you <a href="https://www.benzinga.com//node/42242876">need to know</a>.
What To Know: A filing with the Securities and Exchange Commission reveals that the private placement raised $360,000 in funding and involved participation from several company executives.
The group of investors includes CEO Daniel Widmaier, Interim CFO Randy Beufumo, and Chief Technology Officer David Breslauer.
Bolt Projects is experiencing unusually high trading activity with 49 million shares exchanged in the current session, far exceeding its 100-day average session volume of 833.95 thousand shares.
How To Buy Bolt Projects Shares 
By now you're likely curious about how to participate in the market for Bolt Projects Holdings &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the case of Bolt Projects Holdings, which is trading at $0.86 as of publishing time, $100 would buy you 116.28 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
See Also: <a href="https://www.benzinga.com/real-estate/24/11/42244420/more-freedom-why-joe-rogan-left-l-a-for-a-14-4-million-mansion-on-lake-austin">&#8216;More Freedom&#8217;: Why Joe Rogan Left L.A. For A $14.4 Million Mansion On Lake Austin</a>
BSLK Price Action: At the time of publication, Bolt shares are trading 237.7% higher at 99 cents, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Image via Pexels

BSLK

What's Going On With Bolt Projects Shares Friday?

SOS Ltd. shares are trading higher after the company recently announced that its board of directors approved a $50 million investment to purchase Bitcoin.

Stock Split

APVO

Aptevo Therapeutics Announces 1-For-37 Reverse Stock Split Effective Dec. 3, 2024 At 5:01 p.m. EST

UMAC

Unusual Machines shares are trading higher after the company announced on Wednesday that Donald Trump Jr. has joined its advisory board.

In the current market session, NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) stock price is at $78.41, after a 0.14% decrease. However, over the past month, the company's stock increased by 1.37%, and in the past year, by 33.65%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1732892466_0.png" alt="Past Year Chart" />

<h3>Comparing NextEra Energy P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 19.21 in the Electric Utilities industry, NextEra Energy Inc. has a higher P/E ratio of 23.3. Shareholders might be inclined to think that NextEra Energy Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1732892467_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into NextEra Energy Inc's Price Over Earnings

In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and its primary competitors in the Broadline Retail industry. By closely examining key financial metrics, market position, and growth prospects, our aim is to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>Amazon.com Background</h3>
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amazon.com Inc</td>
<td>43.96</td>
<td>8.35</td>
<td>3.54</td>
<td>6.19%</td>
<td>$32.08</td>
<td>$31.0</td>
<td>11.04%</td>
</tr>
<tr>
<td>Alibaba Group Holding Ltd</td>
<td>17.84</td>
<td>1.57</td>
<td>1.62</td>
<td>4.64%</td>
<td>$54.02</td>
<td>$92.47</td>
<td>5.21%</td>
</tr>
<tr>
<td>PDD Holdings Inc</td>
<td>9.75</td>
<td>3.57</td>
<td>2.83</td>
<td>9.38%</td>
<td>$29.18</td>
<td>$59.65</td>
<td>44.33%</td>
</tr>
<tr>
<td>MercadoLibre Inc</td>
<td>72.53</td>
<td>25.90</td>
<td>5.67</td>
<td>10.37%</td>
<td>$0.72</td>
<td>$2.44</td>
<td>35.27%</td>
</tr>
<tr>
<td>JD.com Inc</td>
<td>11.98</td>
<td>1.71</td>
<td>0.37</td>
<td>5.22%</td>
<td>$15.92</td>
<td>$45.04</td>
<td>5.12%</td>
</tr>
<tr>
<td>Coupang Inc</td>
<td>44.77</td>
<td>10.94</td>
<td>1.59</td>
<td>1.74%</td>
<td>$0.28</td>
<td>$2.27</td>
<td>27.2%</td>
</tr>
<tr>
<td>eBay Inc</td>
<td>16.20</td>
<td>5.68</td>
<td>3.20</td>
<td>11.59%</td>
<td>$0.95</td>
<td>$1.85</td>
<td>3.04%</td>
</tr>
<tr>
<td>Vipshop Holdings Ltd</td>
<td>6.48</td>
<td>1.34</td>
<td>0.49</td>
<td>2.76%</td>
<td>$1.47</td>
<td>$4.96</td>
<td>-9.18%</td>
</tr>
<tr>
<td>Dillard's Inc</td>
<td>11.54</td>
<td>3.62</td>
<td>1.08</td>
<td>6.37%</td>
<td>$0.15</td>
<td>$0.58</td>
<td>-4.19%</td>
</tr>
<tr>
<td>Ollie's Bargain Outlet Holdings Inc</td>
<td>30.82</td>
<td>3.90</td>
<td>2.82</td>
<td>3.14%</td>
<td>$0.08</td>
<td>$0.22</td>
<td>12.41%</td>
</tr>
<tr>
<td>MINISO Group Holding Ltd</td>
<td>18.62</td>
<td>4.32</td>
<td>3.03</td>
<td>6.26%</td>
<td>$0.79</td>
<td>$1.77</td>
<td>24.08%</td>
</tr>
<tr>
<td>Macy's Inc</td>
<td>24.55</td>
<td>1.03</td>
<td>0.19</td>
<td>3.53%</td>
<td>$0.44</td>
<td>$2.16</td>
<td>-3.48%</td>
</tr>
<tr>
<td>Nordstrom Inc</td>
<td>14.32</td>
<td>3.78</td>
<td>0.25</td>
<td>4.75%</td>
<td>$0.4</td>
<td>$1.49</td>
<td>-11.04%</td>
</tr>
<tr>
<td>Kohl's Corp</td>
<td>6.64</td>
<td>0.43</td>
<td>0.10</td>
<td>0.58%</td>
<td>$0.35</td>
<td>$1.6</td>
<td>-0.59%</td>
</tr>
<tr>
<td>Savers Value Village Inc</td>
<td>20.11</td>
<td>3.42</td>
<td>1.02</td>
<td>5.09%</td>
<td>$0.07</td>
<td>$0.22</td>
<td>0.53%</td>
</tr>
<tr>
<td>Groupon Inc</td>
<td>13.57</td>
<td>9.31</td>
<td>0.70</td>
<td>34.72%</td>
<td>$0.03</td>
<td>$0.1</td>
<td>-9.48%</td>
</tr>
<tr>
<td>Average</td>
<td>21.31</td>
<td>5.37</td>
<td>1.66</td>
<td>7.34%</td>
<td>$6.99</td>
<td>$14.45</td>
<td>7.95%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By thoroughly analyzing Amazon.com, we can discern the following trends: 
<ul>
<li>
At 43.96, the stock's Price to Earnings ratio significantly exceeds the industry average by 2.06x, suggesting a premium valuation relative to industry peers.
</li>
<li>
It could be trading at a premium in relation to its book value, as indicated by its Price to Book ratio of 8.35 which exceeds the industry average by 1.55x.
</li>
<li>
The stock's relatively high Price to Sales ratio of 3.54, surpassing the industry average by 2.13x, may indicate an aspect of overvaluation in terms of sales performance.
</li>
<li>
The Return on Equity (ROE) of 6.19% is 1.15% below the industry average, suggesting potential inefficiency in utilizing equity to generate profits.
</li>
<li>
Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $32.08 Billion, which is 4.59x above the industry average, indicating stronger profitability and robust cash flow generation.
</li>
<li>
The company has higher gross profit of $31.0 Billion, which indicates 2.15x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company is experiencing remarkable revenue growth, with a rate of 11.04%, outperforming the industry average of 7.95%.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732892448_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is an important measure to assess the financial structure and risk profile of a company.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
By considering the Debt-to-Equity ratio, Amazon.com can be compared to its top 4 peers, leading to the following observations:
<ul>
<li>
When comparing the debt-to-equity ratio, Amazon.com is in a stronger financial position compared to its top 4 peers.
</li>
<li>
The company has a lower level of debt relative to its equity, indicating a more favorable balance between the two with a lower debt-to-equity ratio of 0.52.
</li>
</ul>
<h3>Key Takeaways</h3>
For Amazon.com, the PE, PB, and PS ratios are all high compared to its peers in the Broadline Retail industry, indicating that the stock may be overvalued. The low ROE suggests that Amazon.com is not generating significant returns on shareholder equity. However, the high EBITDA, gross profit, and revenue growth show that the company is performing well in terms of operational efficiency and revenue generation compared to its industry peers.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

Understanding Amazon.com's Position In Broadline Retail Industry Compared To Competitors

In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and its primary competitors in the Interactive Media &amp; Services industry. By closely examining key financial metrics, market position, and growth prospects, our aim is to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>Meta Platforms Background</h3>
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Platforms Inc</td>
<td>26.86</td>
<td>8.73</td>
<td>9.56</td>
<td>9.77%</td>
<td>$22.06</td>
<td>$33.21</td>
<td>18.87%</td>
</tr>
<tr>
<td>Alphabet Inc</td>
<td>22.44</td>
<td>6.59</td>
<td>6.23</td>
<td>8.55%</td>
<td>$35.74</td>
<td>$51.79</td>
<td>15.09%</td>
</tr>
<tr>
<td>Baidu Inc</td>
<td>11.19</td>
<td>0.83</td>
<td>1.61</td>
<td>2.98%</td>
<td>$9.27</td>
<td>$17.16</td>
<td>-2.58%</td>
</tr>
<tr>
<td>Pinterest Inc</td>
<td>94.75</td>
<td>7.08</td>
<td>6.07</td>
<td>1.0%</td>
<td>$-0.0</td>
<td>$0.71</td>
<td>17.71%</td>
</tr>
<tr>
<td>Kanzhun Ltd</td>
<td>29.05</td>
<td>2.73</td>
<td>6.09</td>
<td>2.92%</td>
<td>$0.36</td>
<td>$1.6</td>
<td>28.85%</td>
</tr>
<tr>
<td>ZoomInfo Technologies Inc</td>
<td>366.67</td>
<td>2.26</td>
<td>3.36</td>
<td>1.35%</td>
<td>$0.07</td>
<td>$0.26</td>
<td>-3.25%</td>
</tr>
<tr>
<td>Yelp Inc</td>
<td>23.22</td>
<td>3.39</td>
<td>1.98</td>
<td>5.21%</td>
<td>$0.06</td>
<td>$0.33</td>
<td>4.41%</td>
</tr>
<tr>
<td>Ziff Davis Inc</td>
<td>43.07</td>
<td>1.41</td>
<td>1.90</td>
<td>-2.68%</td>
<td>$0.02</td>
<td>$0.3</td>
<td>3.69%</td>
</tr>
<tr>
<td>Weibo Corp</td>
<td>6.48</td>
<td>0.64</td>
<td>1.40</td>
<td>3.78%</td>
<td>$0.14</td>
<td>$0.37</td>
<td>5.05%</td>
</tr>
<tr>
<td>JOYY Inc</td>
<td>11.94</td>
<td>0.40</td>
<td>1.10</td>
<td>1.17%</td>
<td>$0.06</td>
<td>$0.21</td>
<td>-1.48%</td>
</tr>
<tr>
<td>Tripadvisor Inc</td>
<td>54.23</td>
<td>2.08</td>
<td>1.16</td>
<td>4.33%</td>
<td>$0.1</td>
<td>$0.48</td>
<td>-0.19%</td>
</tr>
<tr>
<td>Cars.com Inc</td>
<td>33.39</td>
<td>2.54</td>
<td>1.86</td>
<td>3.75%</td>
<td>$0.06</td>
<td>$0.15</td>
<td>3.05%</td>
</tr>
<tr>
<td>Average</td>
<td>63.31</td>
<td>2.72</td>
<td>2.98</td>
<td>2.94%</td>
<td>$4.17</td>
<td>$6.67</td>
<td>6.4%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>Upon a comprehensive analysis of Meta Platforms, the following trends can be discerned: 
<ul>
<li>
At 26.86, the stock's Price to Earnings ratio is 0.42x less than the industry average, suggesting favorable growth potential.
</li>
<li>
With a Price to Book ratio of 8.73, which is 3.21x the industry average, Meta Platforms might be considered overvalued in terms of its book value, as it is trading at a higher multiple compared to its industry peers.
</li>
<li>
The Price to Sales ratio of 9.56, which is 3.21x the industry average, suggests the stock could potentially be overvalued in relation to its sales performance compared to its peers.
</li>
<li>
The company has a higher Return on Equity (ROE) of 9.77%, which is 6.83% above the industry average. This suggests efficient use of equity to generate profits and demonstrates profitability and growth potential.
</li>
<li>
Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $22.06 Billion, which is 5.29x above the industry average, indicating stronger profitability and robust cash flow generation.
</li>
<li>
The company has higher gross profit of $33.21 Billion, which indicates 4.98x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of 18.87% is notably higher compared to the industry average of 6.4%, showcasing exceptional sales performance and strong demand for its products or services.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732892439_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is an important measure to assess the financial structure and risk profile of a company.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
When assessing Meta Platforms against its top 4 peers using the Debt-to-Equity ratio, the following comparisons can be made:
<ul>
<li>
Meta Platforms exhibits a stronger financial position compared to its top 4 peers in the sector, as indicated by its lower debt-to-equity ratio of 0.3.
</li>
<li>
This suggests that the company has a more favorable balance between debt and equity, which can be seen as a positive aspect for investors.
</li>
</ul>
<h3>Key Takeaways</h3>
The PE, PB, and PS ratios for Meta Platforms indicate that it may be overvalued compared to its peers in the Interactive Media &amp; Services industry. However, its high ROE, EBITDA, gross profit, and revenue growth suggest strong operational performance and growth potential relative to industry competitors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Industry Comparison: Evaluating Meta Platforms Against Competitors In Interactive Media &amp; Services Industry

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) in relation to its major competitors in the Technology Hardware, Storage &amp; Peripherals industry. Through a detailed examination of key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and illuminate company's performance in the industry.
<h3>Apple Background</h3>
Apple is among the largest companies in the world, with a broad portfolio of hardware and software products targeted at consumers and businesses. Apple's iPhone makes up a majority of the firm sales, and Apple's other products like Mac, iPad, and Watch are designed around the iPhone as the focal point of an expansive software ecosystem. Apple has progressively worked to add new applications, like streaming video, subscription bundles, and augmented reality. The firm designs its own software and semiconductors while working with subcontractors like Foxconn and TSMC to build its products and chips. Slightly less than half of Apple's sales come directly through its flagship stores, with a majority of sales coming indirectly through partnerships and distribution.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Apple Inc</td>
<td>38.64</td>
<td>62.36</td>
<td>9.26</td>
<td>23.83%</td>
<td>$32.5</td>
<td>$43.88</td>
<td>6.07%</td>
</tr>
<tr>
<td>Hewlett Packard Enterprise Co</td>
<td>14.75</td>
<td>1.22</td>
<td>0.95</td>
<td>2.34%</td>
<td>$1.23</td>
<td>$2.44</td>
<td>10.11%</td>
</tr>
<tr>
<td>NetApp Inc</td>
<td>22.55</td>
<td>27.90</td>
<td>4</td>
<td>32.84%</td>
<td>$0.44</td>
<td>$1.18</td>
<td>6.15%</td>
</tr>
<tr>
<td>Western Digital Corp</td>
<td>78.57</td>
<td>2.12</td>
<td>1.67</td>
<td>4.28%</td>
<td>$0.86</td>
<td>$1.55</td>
<td>48.91%</td>
</tr>
<tr>
<td>Super Micro Computer Inc</td>
<td>17.46</td>
<td>3.75</td>
<td>1.41</td>
<td>6.68%</td>
<td>$0.4</td>
<td>$0.6</td>
<td>37.87%</td>
</tr>
<tr>
<td>Pure Storage Inc</td>
<td>122.45</td>
<td>11.93</td>
<td>6.14</td>
<td>2.52%</td>
<td>$0.08</td>
<td>$0.54</td>
<td>10.91%</td>
</tr>
<tr>
<td>Eastman Kodak Co</td>
<td>10.20</td>
<td>0.58</td>
<td>0.62</td>
<td>1.34%</td>
<td>$0.04</td>
<td>$0.04</td>
<td>-2.97%</td>
</tr>
<tr>
<td>Turtle Beach Corp</td>
<td>54.55</td>
<td>3.33</td>
<td>1.01</td>
<td>3.3%</td>
<td>$0.01</td>
<td>$0.03</td>
<td>59.51%</td>
</tr>
<tr>
<td>Immersion Corp</td>
<td>4.90</td>
<td>1.23</td>
<td>1.74</td>
<td>13.41%</td>
<td>$0.03</td>
<td>$0.06</td>
<td>1323.8%</td>
</tr>
<tr>
<td>AstroNova Inc</td>
<td>17.88</td>
<td>1.23</td>
<td>0.76</td>
<td>-0.34%</td>
<td>$0.0</td>
<td>$0.01</td>
<td>14.12%</td>
</tr>
<tr>
<td>Average</td>
<td>38.15</td>
<td>5.92</td>
<td>2.03</td>
<td>7.37%</td>
<td>$0.34</td>
<td>$0.72</td>
<td>167.6%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>When conducting a detailed analysis of Apple, the following trends become clear: 
<ul>
<li>
At 38.64, the stock's Price to Earnings ratio significantly exceeds the industry average by 1.01x, suggesting a premium valuation relative to industry peers.
</li>
<li>
It could be trading at a premium in relation to its book value, as indicated by its Price to Book ratio of 62.36 which exceeds the industry average by 10.53x.
</li>
<li>
The stock's relatively high Price to Sales ratio of 9.26, surpassing the industry average by 4.56x, may indicate an aspect of overvaluation in terms of sales performance.
</li>
<li>
The Return on Equity (ROE) of 23.83% is 16.46% above the industry average, highlighting efficient use of equity to generate profits.
</li>
<li>
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $32.5 Billion is 95.59x above the industry average, highlighting stronger profitability and robust cash flow generation.
</li>
<li>
Compared to its industry, the company has higher gross profit of $43.88 Billion, which indicates 60.94x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company is witnessing a substantial decline in revenue growth, with a rate of 6.07% compared to the industry average of 167.6%, which indicates a challenging sales environment.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732892430_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is a key indicator of a company's financial health and its reliance on debt financing.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
When comparing Apple with its top 4 peers based on the Debt-to-Equity ratio, the following insights can be observed:
<ul>
<li>
Apple holds a middle position in terms of the debt-to-equity ratio compared to its top 4 peers.
</li>
<li>
This indicates a balanced financial structure with a moderate level of debt and an appropriate reliance on equity financing with a debt-to-equity ratio of 1.87.
</li>
</ul>
<h3>Key Takeaways</h3>
For Apple in the Technology Hardware, Storage &amp; Peripherals industry, the PE, PB, and PS ratios are all high compared to its peers, indicating that the stock may be overvalued. On the other hand, Apple's high ROE, EBITDA, gross profit, and low revenue growth suggest strong profitability and operational efficiency relative to industry competitors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

Investigating Apple's Standing In Technology Hardware, Storage &amp; Peripherals Industry Compared To Competitors

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) in comparison to its major competitors within the Software industry. By analyzing critical financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding of company's performance in the industry.
<h3>Microsoft Background</h3>
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Microsoft Corp</td>
<td>34.93</td>
<td>10.93</td>
<td>12.43</td>
<td>8.87%</td>
<td>$38.23</td>
<td>$45.49</td>
<td>16.04%</td>
</tr>
<tr>
<td>Oracle Corp</td>
<td>47.09</td>
<td>46.81</td>
<td>9.61</td>
<td>30.01%</td>
<td>$5.44</td>
<td>$9.4</td>
<td>6.86%</td>
</tr>
<tr>
<td>ServiceNow Inc</td>
<td>162.21</td>
<td>23.13</td>
<td>20.67</td>
<td>4.81%</td>
<td>$0.67</td>
<td>$2.21</td>
<td>22.25%</td>
</tr>
<tr>
<td>Palo Alto Networks Inc</td>
<td>49.85</td>
<td>21.33</td>
<td>16.47</td>
<td>6.33%</td>
<td>$0.45</td>
<td>$1.58</td>
<td>13.88%</td>
</tr>
<tr>
<td>CrowdStrike Holdings Inc</td>
<td>681.55</td>
<td>28</td>
<td>23.24</td>
<td>-0.57%</td>
<td>$0.05</td>
<td>$0.76</td>
<td>28.52%</td>
</tr>
<tr>
<td>Fortinet Inc</td>
<td>47.27</td>
<td>79.39</td>
<td>12.70</td>
<td>90.26%</td>
<td>$0.66</td>
<td>$1.24</td>
<td>13.0%</td>
</tr>
<tr>
<td>Gen Digital Inc</td>
<td>31.15</td>
<td>9.06</td>
<td>5.05</td>
<td>7.92%</td>
<td>$0.51</td>
<td>$0.78</td>
<td>3.07%</td>
</tr>
<tr>
<td>Monday.Com Ltd</td>
<td>667.33</td>
<td>14.73</td>
<td>16.27</td>
<td>-1.28%</td>
<td>$-0.02</td>
<td>$0.23</td>
<td>32.67%</td>
</tr>
<tr>
<td>CommVault Systems Inc</td>
<td>43.56</td>
<td>27.02</td>
<td>8.63</td>
<td>5.56%</td>
<td>$0.02</td>
<td>$0.19</td>
<td>16.06%</td>
</tr>
<tr>
<td>Dolby Laboratories Inc</td>
<td>29.07</td>
<td>3.01</td>
<td>5.98</td>
<td>2.39%</td>
<td>$0.07</td>
<td>$0.27</td>
<td>4.9%</td>
</tr>
<tr>
<td>QXO Inc</td>
<td>29.44</td>
<td>1.51</td>
<td>26.82</td>
<td>-0.21%</td>
<td>$-0.03</td>
<td>$0.01</td>
<td>-2.0%</td>
</tr>
<tr>
<td>Qualys Inc</td>
<td>34.15</td>
<td>12.59</td>
<td>9.79</td>
<td>10.53%</td>
<td>$0.05</td>
<td>$0.13</td>
<td>8.36%</td>
</tr>
<tr>
<td>Teradata Corp</td>
<td>36.39</td>
<td>23.68</td>
<td>1.70</td>
<td>32.0%</td>
<td>$0.08</td>
<td>$0.27</td>
<td>0.46%</td>
</tr>
<tr>
<td>Progress Software Corp</td>
<td>36.32</td>
<td>6.81</td>
<td>4.19</td>
<td>6.88%</td>
<td>$0.06</td>
<td>$0.15</td>
<td>2.11%</td>
</tr>
<tr>
<td>SolarWinds Corp</td>
<td>59.73</td>
<td>1.64</td>
<td>2.87</td>
<td>0.94%</td>
<td>$0.07</td>
<td>$0.18</td>
<td>5.5%</td>
</tr>
<tr>
<td>Average</td>
<td>139.65</td>
<td>21.34</td>
<td>11.71</td>
<td>13.97%</td>
<td>$0.58</td>
<td>$1.24</td>
<td>11.12%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By closely studying Microsoft, we can observe the following trends: 
<ul>
<li>
At 34.93, the stock's Price to Earnings ratio is 0.25x less than the industry average, suggesting favorable growth potential.
</li>
<li>
The current Price to Book ratio of 10.93, which is 0.51x the industry average, is substantially lower than the industry average, indicating potential undervaluation.
</li>
<li>
The Price to Sales ratio of 12.43, which is 1.06x the industry average, suggests the stock could potentially be overvalued in relation to its sales performance compared to its peers.
</li>
<li>
The company has a lower Return on Equity (ROE) of 8.87%, which is 5.1% below the industry average. This indicates potential inefficiency in utilizing equity to generate profits, which could be attributed to various factors.
</li>
<li>
Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $38.23 Billion, which is 65.91x above the industry average, indicating stronger profitability and robust cash flow generation.
</li>
<li>
The company has higher gross profit of $45.49 Billion, which indicates 36.69x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of 16.04% exceeds the industry average of 11.12%, indicating strong sales performance and market outperformance.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732892421_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio provides insights into the proportion of debt a company has in relation to its equity and asset value.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In terms of the Debt-to-Equity ratio, Microsoft stands in comparison with its top 4 peers, leading to the following comparisons:
<ul>
<li>
Microsoft has a stronger financial position compared to its top 4 peers, as evidenced by its lower debt-to-equity ratio of 0.21.
</li>
<li>
This suggests that the company has a more favorable balance between debt and equity, which can be perceived as a positive indicator by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
For Microsoft in the Software industry, the PE and PB ratios suggest the stock is undervalued compared to peers, indicating potential for growth. However, the high PS ratio implies the stock may be overvalued based on revenue. In terms of ROE, EBITDA, gross profit, and revenue growth, Microsoft shows strong performance and growth potential compared to industry peers.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSFT

Evaluating Microsoft Against Peers In Software Industry

Oragenics prices public offering of common stock

Oragenics unveils automated intranasal device for treating concussed patients

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Oragenics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ogen-stock-quote/">OGEN</a>) just reported results for the fourth quarter of 2023.<ul><li>Oragenics reported earnings per share of -$5.48.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/ogen-stock-earnings-oragenics-for-q4-of-2023/">OGEN Stock Earnings: Oragenics Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OGEN Stock Earnings: Oragenics Reported Results for Q4 2023

Earnings Week Ahead: Walmart, Home Depot, Alibaba, Cisco and more

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Oragenics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ogen-stock-quote/">OGEN</a>) just reported results for the second quarter of 2024.<ul><li>Oragenics reported earnings per share of -51 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ogen-stock-earnings-oragenics-for-q2-of-2024/">OGEN Stock Earnings: Oragenics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OGEN Stock Earnings: Oragenics Reported Results for Q2 2024

Oragenics files to sell 2.4M shares of common stock

Oragenics stock plummets on selling 8.1M shares at $0.55 in public offering

An update from Oragenics ( ($OGEN) ) is now available. On September 19, 2024, the Compensation Committee and Board of Directors of a company awarde...

Oragenics Executive Compensation and Shareholder Meeting Updates

Oragenics ( ($OGEN) ) just unveiled an update. Oragenics, Inc. is poised to engage potential investors and industry analysts with its latest presen...

Oragenics Shares Investor Presentation Online

Earnings week ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and more

ABEO

AMAT

ASTS

ASXC

ATOS

AVXL

AYRO

BABA

BATL

BEEM

BEKE

BIDU

BLDP

BLUE

BTBT

BZUN

CARA

CATX

CMCM

COCP

CPRT

CRNC

CSCO

CTRM

EBON

ESLT

ESPR

ESTC

FUTU

GALT

GASS

GLNG

GOEV

GOLD

GRAB

HUYA

IMMR

INTU

JAGX

KEYS

KNDI

LITE

MBOT

MDAI

MIRA

MMAT

MNDY

NEGG

NNDM

NNOX

NTAP

NVDA

OCSL

OGEN

OUST

PANW

PSFE

ROST

RRAC

SACH

SBLK

SNOW

STNE

TAYD

TCEHY

TCOM

TCRT

TWST

UAVS

VIPS

VUZI

WKHS

XPEV

XXII

Health Care

Press Releases

Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

"Explosive Growth Stocks: Innovations, Strategy, Earners Unlock Prime Potential CXAI, OGEN, PRSO, INBS, KAVL"

Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

Oragenics, Inc. Announces Pricing of Public Offering

Financing

Oragenics, Inc. Announces Closing of Public Offering

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

Comments

Oragenics

空売り

Oragenics (AMEX:OGEN) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル